StockNews.AISignal intelligencePublic signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Positive analyst sentiment (RBC buy rating, $175 target) plus CHRD’s strong balance sheet and high FCF payout suggest potential multiple expansion and upside to earnings power in 2026–2027, despite macro headwinds.
What happened, with direct paths to the underlying reporting
RBC reiterates a buy on CHRD with a $175 target, citing robust 2026 output and a best-in-class balance sheet. The note points to Q3 2026 production near 283 Mboe/d, an 80% free cash flow payout, and about $375 million in capex, with 2027 capital plans and Williston Basin M&A as potential upside drivers.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.